174 related articles for article (PubMed ID: 32123046)
1. Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging.
Bezukladova S; Tuisku J; Matilainen M; Vuorimaa A; Nylund M; Smith S; Sucksdorff M; Mohammadian M; Saunavaara V; Laaksonen S; Rokka J; Rinne JO; Rissanen E; Airas L
Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32123046
[TBL] [Abstract][Full Text] [Related]
2. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
Herranz E; Giannì C; Louapre C; Treaba CA; Govindarajan ST; Ouellette R; Loggia ML; Sloane JA; Madigan N; Izquierdo-Garcia D; Ward N; Mangeat G; Granberg T; Klawiter EC; Catana C; Hooker JM; Taylor N; Ionete C; Kinkel RP; Mainero C
Ann Neurol; 2016 Nov; 80(5):776-790. PubMed ID: 27686563
[TBL] [Abstract][Full Text] [Related]
3. Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study.
Saraste M; Bezukladova S; Sucksdorff M; Saunavaara V; Rissanen E; Matilainen M; Airas L
Mult Scler Relat Disord; 2021 Feb; 48():102690. PubMed ID: 33352357
[TBL] [Abstract][Full Text] [Related]
4. Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTI.
Saraste M; Bezukladova S; Matilainen M; Sucksdorff M; Kuhle J; Leppert D; Airas L
Mult Scler Relat Disord; 2021 May; 50():102810. PubMed ID: 33556656
[TBL] [Abstract][Full Text] [Related]
5. Microstructural alterations in different types of lesions and their perilesional white matter in relapsing-remitting multiple sclerosis based on diffusion kurtosis imaging.
Shi Z; Pan Y; Yan Z; Ding S; Hu H; Wei Y; Luo D; Xu Y; Zhu Q; Li Y
Mult Scler Relat Disord; 2023 Mar; 71():104572. PubMed ID: 36821979
[TBL] [Abstract][Full Text] [Related]
6. Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study.
Zivadinov R; Bergsland N; Hagemeier J; Tavazzi E; Ramasamy DP; Durfee J; Cherneva M; Carl E; Carl J; Kolb C; Hojnacki D; Weinstock-Guttman B
J Neurol Sci; 2018 Apr; 387():152-156. PubMed ID: 29571854
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of microstructural abnormalities in multiple sclerosis detected with NODDI and DTI models of diffusion-weighted magnetic resonance imaging.
Caranova M; Soares JF; Batista S; Castelo-Branco M; Duarte JV
Magn Reson Imaging; 2023 Dec; 104():61-71. PubMed ID: 37775062
[TBL] [Abstract][Full Text] [Related]
8. Characterization of normal-appearing white matter in multiple sclerosis using quantitative susceptibility mapping in conjunction with diffusion tensor imaging.
Yu FF; Chiang FL; Stephens N; Huang SY; Bilgic B; Tantiwongkosi B; Romero R
Neuroradiology; 2019 Jan; 61(1):71-79. PubMed ID: 30539215
[TBL] [Abstract][Full Text] [Related]
9. T1/T2 ratio: A quantitative sensitive marker of brain tissue integrity in multiple sclerosis.
Hannoun S; Kocevar G; Codjia P; Barile B; Cotton F; Durand-Dubief F; Sappey-Marinier D
J Neuroimaging; 2022 Mar; 32(2):328-336. PubMed ID: 34752685
[TBL] [Abstract][Full Text] [Related]
10. Neural diffusion tensor imaging metrics correlate with clinical measures in people with relapsing-remitting MS.
Alshehri A; Al-Iedani O; Arm J; Gholizadeh N; Billiet T; Lea R; Lechner-Scott J; Ramadan S
Neuroradiol J; 2022 Oct; 35(5):592-599. PubMed ID: 35118885
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
Rissanen E; Tuisku J; Rokka J; Paavilainen T; Parkkola R; Rinne JO; Airas L
J Nucl Med; 2014 Jun; 55(6):939-44. PubMed ID: 24711650
[TBL] [Abstract][Full Text] [Related]
12. Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures.
Zivadinov R; Bergsland N; Hagemeier J; Carl E; Kolb H; Hojnacki D; Weinstock-Guttman B
J Neurol Sci; 2018 May; 388():175-181. PubMed ID: 29627017
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of patients with relapsing-remitting multiple sclerosis using tract-based spatial statistics analysis: diffusion kurtosis imaging.
Li HQ; Yin B; Quan C; Geng DY; Yu H; Bao YF; Liu J; Li YX
BMC Neurol; 2018 Aug; 18(1):108. PubMed ID: 30086721
[TBL] [Abstract][Full Text] [Related]
14. (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
Park E; Gallezot JD; Delgadillo A; Liu S; Planeta B; Lin SF; O'Connor KC; Lim K; Lee JY; Chastre A; Chen MK; Seneca N; Leppert D; Huang Y; Carson RE; Pelletier D
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1081-92. PubMed ID: 25833352
[TBL] [Abstract][Full Text] [Related]
15. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
[TBL] [Abstract][Full Text] [Related]
16. Diffusion tensor imaging changes of the cortico-thalamic-striatal tracts correlate with fatigue and disability in people with relapsing-remitting MS.
Alshehri A; Koussis N; Al-Iedani O; Arm J; Khormi I; Lea S; Lea R; Ramadan S; Lechner-Scott J
Eur J Radiol; 2024 Jan; 170():111207. PubMed ID: 37988961
[TBL] [Abstract][Full Text] [Related]
17. Diffusion tensor imaging of normal-appearing white matter in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
Kim SH; Kwak K; Hyun JW; Joung A; Lee SH; Choi YH; Lee JM; Kim HJ
Eur J Neurol; 2017 Jul; 24(7):966-973. PubMed ID: 28643955
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis.
Sucksdorff M; Rissanen E; Tuisku J; Nuutinen S; Paavilainen T; Rokka J; Rinne J; Airas L
J Nucl Med; 2017 Oct; 58(10):1646-1651. PubMed ID: 28336784
[TBL] [Abstract][Full Text] [Related]
19. Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study.
Zivadinov R; Hagemeier J; Bergsland N; Tavazzi E; Weinstock-Guttman B
Eur J Neurol; 2018 Mar; 25(3):584-e36. PubMed ID: 29316038
[TBL] [Abstract][Full Text] [Related]
20. Fatigue in multiple sclerosis: The contribution of occult white matter damage.
Bisecco A; Caiazzo G; d'Ambrosio A; Sacco R; Bonavita S; Docimo R; Cirillo M; Pagani E; Filippi M; Esposito F; Tedeschi G; Gallo A
Mult Scler; 2016 Nov; 22(13):1676-1684. PubMed ID: 26846989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
